Speaker programmes remain key in boosting the adoption of a drug. In recent years programmes have centred more on education rather than promotion of a specific brand. This shift can largely be attributed to the scrutiny focused on the relationships between doctors and life science companies. Todd Middleton at Cutting Edge Information delves into how existing and developing regulations surrounding healthcare provider (HCP) compensation emphasise staying compliant when contracting medical professionals for their services.